I-SCRIBBLE: Tracking blood biomarkers after spinal cord injury
Official title: The International Spinal Cord Injury Blood Biomarker Longitudinal Evaluation (I-SCRIBBLE) Study
Run by AO Foundation, AO Spine · NCT06839300 · Data updated 2026-11-12
This project will test whether blood levels of NF-L and GFAP taken soon after a traumatic spinal cord injury can help predict whether someone will have motor-complete or motor-incomplete impairment at six months.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 260 (estimated) |
| Sponsor | AO Foundation, AO Spine Academic / other |
| Locations | 8 sites (Milwaukee, Wisconsin and 7 other locations) |
| Status | Recruiting |
| Started | February 9, 2026 |
| Main results expected | December 1, 2029 |
| Study ends | December 1, 2029 |
| Registry record updated | October 1, 2026 |
| Trial ID | NCT06839300 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (aged 19 or older) with acute blunt traumatic spinal cord injury between C0 and L1 who can provide informed consent and have an initial blood draw within 24 hours of injury are ideal candidates.
✕Probably not a fit
People with penetrating spinal injuries, prior spinal cord injury, injuries outside C0–L1, or who cannot provide a blood sample within 24 hours are not eligible and would not benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with acute blunt (non-penetrating) spinal cord injury will be enrolled at participating hospitals and have blood drawn within 24 hours of injury, daily through Day 7, and again at 6 and 12 months. Samples (serum, plasma, and RNA/DNA aliquots) are processed locally then sent to a central lab in Vancouver for storage and analysis. NF-L and GFAP concentrations will be measured on the Quanterix Simoa platform and compared with clinical neurologic exams (including ISNCSCI) to see how well early biomarker levels stratify injury severity and predict 6-month motor outcome. A control group of adults with traumatic spinal column injury but no spinal cord injury will be enrolled for comparison.
Why it matters
Potential benefit: If successful, this could provide an early blood test to help predict long-term motor outcome after traumatic spinal cord injury.
How similar studies have gone: Prior research using NF-L and GFAP measured with ultrasensitive assays has shown promising correlations with neurologic injury severity in traumatic brain and spinal cord injury, but large multicenter longitudinal validation remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 19 years * Blunt (non-penetrating) traumatic SCI * Baseline neurologic impairment deemed "complete" (AIS grade A) or "incomplete" (AIS grade B, C, or D) based on clinical history/examination and/or diagnostic imaging * Bony spinal level involvement between C0 and L1, inclusive * Ability to have initial blood sample drawn within 24 hours of injury * Treated either surgically or non-surgically * Ability to provide informed consent according to the IRB/EC defined and approved procedures Inclusion criteria for non-spinal cord injury spinal trauma control participants: * Age ≥ 19 years * Traumatic spinal fracture and/or dislocation between C0 and L1 (inclusive) without SCI * Treated either surgically or nonsurgically * Ability to have initial blood sample drawn within 24 hours of injury * Ability to provide informed consent according to the IRB/EC defined and approved procedures Exclusion Criteria: * Penetrating SCI (eg, gunshot, stab) * Previous SCI * Isolated spinal injury below L1 * Isolated radiculopathy without fracture * Isolated cauda equina injury * Patients with known diagnosis of multiple sclerosis * Preexisting thromboembolic disease or coagulopathy (disorders related to blood clotting), such as hemophilia or von Willebrand disease * Patients who in the investigator's opinion will not be compliant with the study procedures and patients who have any other conditions/injuries that in the investigator's opinion would render the study procedures dangerous
Where it's running
-
Medical College of Wisconsin
Milwaukee, Wisconsin, United States Recruiting -
Clinica Alemana de Santiago
Santiago, Vitacura, Chile Recruiting -
Prince of Wales Hospital
Sydney, Randwick NSW, Australia Not yet recruiting -
Cajuru University Hospital
Curitiba, Paraná, Brazil Terminated -
Charité Berlin
Berlin, Germany Not yet recruiting -
Sri Balaji Action Medical Institute
New Delhi, India Not yet recruiting
Show 2 more locations
-
MIddlemore Hospital
Auckland, Otahuhu, New Zealand Not yet recruiting -
King's College Hospital
London, United Kingdom Not yet recruiting
Study contacts
- Principal investigator: Brian Kwon, MD, PhD, FRCSC — The University of British Columbia
- Study coordinator: Alix Frischknecht
- Email: alix.frischknecht@aofoundation.org
- Phone: +41 79 606 41 48
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Implanted Brain-Computer Interface to Help People with Severe Arm Impairment
We’re testing the N1 System, a fully implanted brain interface in the motor cortex with a robot, to see if it can help adults with spinal cord injury, ALS, or chronic stroke use a computer or keyboard more easily.
-
tSCS with rehabilitation for improving movement after spinal cord injury
This study tests whether adding rehabilitation training to transcutaneous spinal cord stimulation helps paraplegic patients regain voluntary movement after spinal cord injury.
-
Informational Needs of Caregivers of Patients in Neuro Rehab: Validating the QBI-R/V
This study tests a caregiver questionnaire (QBI-R and QBI-V) to see how well it measures caregivers’ informational needs during neuromotor rehabilitation.
-
Biomechanical and Perceived Effort in Manual Wheelchair Propulsion
This study tests whether combining objective shoulder loading data with how hard people feel they’re working can reveal how difficult manual wheelchair propulsion is for users with spinal cord injury.
-
Shockwave therapy added to toxin injections to help spasticity after spinal cord injury
Aims to see if focused shockwave therapy plus Botox injections reduce spasticity better than Botox alone in adults with spinal cord injury.
-
Vibratory Genital Nerve Stimulation to Help Female Sexual Function After Spinal Cord Injury
This study tests whether a home-use vibration device can improve sexual function in cisgender women with spinal cord injury by increasing genital blood flow during arousal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.